Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Monard SC"'
Autor:
Maio M; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France.; Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad de Buenos Aires, Buenos Aires, Argentina., Barros J; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France.; Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad de Buenos Aires, Buenos Aires, Argentina., Joly M; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Vahlas Z; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Marín Franco JL; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France., Genoula M; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France., Monard SC; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Vecchione MB; Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad de Buenos Aires, Buenos Aires, Argentina., Fuentes F; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina., Gonzalez Polo V; Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad de Buenos Aires, Buenos Aires, Argentina., Quiroga MF; Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad de Buenos Aires, Buenos Aires, Argentina., Vermeulen M; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina., Vu Manh TP; Aix Marseille University, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France., Argüello RJ; Aix Marseille University, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France., Inwentarz S; Instituto Prof. Dr. Raúl Vaccarezza and Hospital de Infecciosas Dr. F.J. Muñiz, Buenos Aires, Argentina., Musella R; Instituto Prof. Dr. Raúl Vaccarezza and Hospital de Infecciosas Dr. F.J. Muñiz, Buenos Aires, Argentina., Ciallella L; Instituto Prof. Dr. Raúl Vaccarezza and Hospital de Infecciosas Dr. F.J. Muñiz, Buenos Aires, Argentina., González Montaner P; Instituto Prof. Dr. Raúl Vaccarezza and Hospital de Infecciosas Dr. F.J. Muñiz, Buenos Aires, Argentina., Palmero D; Instituto Prof. Dr. Raúl Vaccarezza and Hospital de Infecciosas Dr. F.J. Muñiz, Buenos Aires, Argentina., Lugo Villarino G; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Sasiain MDC; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France., Neyrolles O; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Vérollet C; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Balboa L; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires, Argentina.; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina / International Research Project Toulouse, Toulouse, France.; Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - Universidad de Buenos Aires, Buenos Aires, Argentina.
Publikováno v:
ELife [Elife] 2024 Jun 26; Vol. 12. Date of Electronic Publication: 2024 Jun 26.
Autor:
Dupont M; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Buenos Aires, Argentina.; The Sir William Dunn School of Pathology, The University of Oxford, Oxford, UK., Rousset S; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.; Department of Infectious and Tropical Diseases, Toulouse University Hospital, Toulouse Cedex, France., Manh TV; Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France., Monard SC; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Buenos Aires, Argentina., Pingris K; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France., Souriant S; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France., Vahlas Z; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Buenos Aires, Argentina., Velez T; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France., Poincloux R; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Buenos Aires, Argentina., Maridonneau-Parini I 1st; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Buenos Aires, Argentina., Neyrolles O; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Buenos Aires, Argentina., Lugo-Villarino G; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Buenos Aires, Argentina., Vérollet C; Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Toulouse, France.; International Research Project (IRP) CNRS 'MAC-TB/HIV', Buenos Aires, Argentina.
Publikováno v:
Journal of leukocyte biology [J Leukoc Biol] 2022 Nov; Vol. 112 (5), pp. 1329-1342. Date of Electronic Publication: 2022 May 19.
Autor:
Bernard-Raichon L; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France; lugo@ipbs.fr lucie.bernard03@gmail.com., Colom A; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Monard SC; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Namouchi A; Centre for Integrative Genetics, Norwegian University of Life Sciences, As, Norway; and., Cescato M; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Garnier H; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Leon-Icaza SA; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Métais A; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Dumas A; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Corral D; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Ghebrendrias N; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Guilloton P; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Vérollet C; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Hudrisier D; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Remot A; Micalis Institute, INRAE, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France., Langella P; Micalis Institute, INRAE, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France., Thomas M; Micalis Institute, INRAE, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France., Cougoule C; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Neyrolles O; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Lugo-Villarino G; Institut de Pharmacologie et Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France; lugo@ipbs.fr lucie.bernard03@gmail.com.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2021 Oct 01; Vol. 207 (7), pp. 1857-1870. Date of Electronic Publication: 2021 Sep 03.
Autor:
Daussy CF; CNRS UMR 3569, Hepacivirus and Innate Immunity, Institut Pasteur, Paris, France., Monard SC; CNRS UMR 3569, Hepacivirus and Innate Immunity, Institut Pasteur, Paris, France.; École Normale Supérieure de Lyon, Lyon, France.; Université Claude Bernard Lyon I, Lyon, France.; Université de Lyon, Lyon, France., Guy C; CIRI, INSERM, U1111, Université Claude Bernard Lyon 1, Lyon, France.; CNRS, UMR5308, École Normale Supérieure de Lyon, Lyon, France.; Université de Lyon, Lyon, France., Muñoz-González S; CIRI, INSERM, U1111, Université Claude Bernard Lyon 1, Lyon, France.; CNRS, UMR5308, École Normale Supérieure de Lyon, Lyon, France.; Université de Lyon, Lyon, France., Chazal M; CNRS UMR 3569, Virology Department, Institut Pasteur, Paris, France., Anthonsen MW; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Jouvenet N; CNRS UMR 3569, Virology Department, Institut Pasteur, Paris, France., Henry T; CIRI, INSERM, U1111, Université Claude Bernard Lyon 1, Lyon, France.; CNRS, UMR5308, École Normale Supérieure de Lyon, Lyon, France.; Université de Lyon, Lyon, France., Dreux M; CIRI, INSERM, U1111, Université Claude Bernard Lyon 1, Lyon, France.; CNRS, UMR5308, École Normale Supérieure de Lyon, Lyon, France.; Université de Lyon, Lyon, France., Meurs EF; CNRS UMR 3569, Hepacivirus and Innate Immunity, Institut Pasteur, Paris, France., Hansen MD; CNRS UMR 3569, Hepacivirus and Innate Immunity, Institut Pasteur, Paris, France marianne.hansen@ntnu.no.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Clinic of Laboratory Medicine, Department of Medical Microbiology, St. Olavs Hospital, Trondheim, Norway.
Publikováno v:
Journal of virology [J Virol] 2021 Jan 13; Vol. 95 (3). Date of Electronic Publication: 2021 Jan 13 (Print Publication: 2021).
Autor:
Ge C; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.; School of Medicine, Tsinghua University, Beijing, China., Monk IR; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Monard SC; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Bedford JG; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Braverman J; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Stinear TP; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Wakim LM; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.
Publikováno v:
Immunology and cell biology [Immunol Cell Biol] 2020 Aug; Vol. 98 (7), pp. 577-594. Date of Electronic Publication: 2020 Jun 08.